Submitted by chz4003 on August 12, 2019 - 1:41pm
Title | Healthcare Costs of Post-Prostate Biopsy Sepsis. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Gross MD, Alshak MN, Shoag JE, Laviana AA, Gorin MA, Sedrakyan A, Hu JC |
Journal | Urology |
Date Published | 2019 Jun 21 |
ISSN | 1527-9995 |
Abstract | Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models. |
DOI | 10.1016/j.urology.2019.06.011 |
Alternate Journal | Urology |
PubMed ID | 31229516 |
Division:
Comparative Effectiveness & Outcomes Research
Category:
Faculty Publication